The estimated Net Worth of Eve Elizabeth Slater is at least $5.27 Milione dollars as of 29 May 2007. Eve Slater owns over 10,000 units of Vertex Pharmaceuticals stock worth over $5,271,988 and over the last 20 years Eve sold VRTX stock worth over $0.
Eve has made over 3 trades of the Vertex Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Eve exercised 10,000 units of VRTX stock worth $133,200 on 29 May 2007.
The largest trade Eve's ever made was exercising 10,000 units of Vertex Pharmaceuticals stock on 29 May 2007 worth over $133,200. On average, Eve trades about 854 units every 33 days since 2004. As of 29 May 2007 Eve still owns at least 11,105 units of Vertex Pharmaceuticals stock.
You can see the complete history of Eve Slater stock trades at the bottom of the page.
Eve's mailing address filed with the SEC is 19 KENILWORTH DRIVE, , SHORT HILLS, NJ, 07078.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden e Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: